These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 16826480

  • 1. Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization.
    Batzloff MR, Hartas J, Zeng W, Jackson DC, Good MF.
    J Infect Dis; 2006 Aug 01; 194(3):325-30. PubMed ID: 16826480
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.
    Zaman M, Abdel-Aal AB, Fujita Y, Ziora ZM, Batzloff MR, Good MF, Toth I.
    J Med Chem; 2012 Oct 11; 55(19):8515-23. PubMed ID: 22974133
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.
    Abdel-Aal AB, Zaman M, Fujita Y, Batzloff MR, Good MF, Toth I.
    J Med Chem; 2010 Nov 25; 53(22):8041-6. PubMed ID: 21028828
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.
    Abdel-Aal AB, Batzloff MR, Fujita Y, Barozzi N, Faria A, Simerska P, Moyle PM, Good MF, Toth I.
    J Med Chem; 2008 Jan 10; 51(1):167-72. PubMed ID: 18072728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.
    Simerska P, Abdel-Aal AB, Fujita Y, Moyle PM, McGeary RP, Batzloff MR, Olive C, Good MF, Toth I.
    J Med Chem; 2008 Mar 13; 51(5):1447-52. PubMed ID: 18278857
    [Abstract] [Full Text] [Related]

  • 13. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.
    Mannam P, Jones KF, Geller BL.
    Infect Immun; 2004 Jun 13; 72(6):3444-50. PubMed ID: 15155651
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N, Olive C, Pruksachatkunakorn C, Pruksakorn S.
    BMC Microbiol; 2006 Aug 09; 6():71. PubMed ID: 16895610
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.
    Moyle PM, Olive C, Ho MF, Good MF, Toth I.
    J Med Chem; 2006 Oct 19; 49(21):6364-70. PubMed ID: 17034142
    [Abstract] [Full Text] [Related]

  • 17. Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes.
    Schulze K, Olive C, Ebensen T, Guzmán CA.
    Vaccine; 2006 Aug 28; 24(35-36):6088-95. PubMed ID: 16828529
    [Abstract] [Full Text] [Related]

  • 18. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H, Dey N, Gupta S, Sharma AK, Kumar R, McMillan D, Good MF.
    Res Microbiol; 2005 May 28; 156(4):575-82. PubMed ID: 15862457
    [Abstract] [Full Text] [Related]

  • 19. Immune response to superoxide dismutase in group A streptococcal infection.
    McMillan DJ, Davies MR, Good MF, Sriprakash KS.
    FEMS Immunol Med Microbiol; 2004 Apr 09; 40(3):249-56. PubMed ID: 15039102
    [Abstract] [Full Text] [Related]

  • 20. Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation.
    Moyle PM, Olive C, Ho MF, Burgess M, Karpati L, Good MF, Toth I.
    J Org Chem; 2006 Sep 01; 71(18):6846-50. PubMed ID: 16930036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.